Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

S&P Biotech Bear -3X Direxion (NY: LABD )

21.18 +0.34 (+1.63%)
Streaming Delayed Price Updated: 1:17 PM EDT, Sep 25, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,063,722
Open 21.13
Bid (Size) 21.16 (35)
Ask (Size) 21.17 (15)
Prev. Close 20.84
Today's Range 21.13 - 21.59
52wk Range 11.18 - 29.19
Shares Outstanding 35,160
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
5 Inverse ETFs That Gained In Double Digits In August
August was a dull month for Wall Street, with all three major indices finishing in the red. This resulted in huge demand for inverse or inverse-leveraged ETFs, as these often fetch outsized returns on... 
Via Talk Markets
Topics ETFs
Inverse ETFs Soar as Market Turns Sour
After an astounding rally, Wall Street has been caught in feeble trading in the past week, triggered by the U.S. credit rating downgrade and now bank downgrades. 
Via Talk Markets

Performance

YTD
+16.89%
+16.89%
1 Month
+26.37%
+26.37%
3 Month
+46.68%
+46.68%
6 Month
-2.35%
-2.35%
1 Year
-27.24%
-27.24%

More News

Read More
Want Diversified Upside in Biotechnology? Check out LABU
Via MarketBeat
Topics ETFs Stocks
Exposures US Equities
5 Best Inverse-Leveraged ETFs Of February
Via Talk Markets
Stocks See Worst Day in 2 Years: Inverse ETFs Shine
Via Talk Markets
5 Inverse ETFs Enjoying A Rally This Year
Via Talk Markets
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
5 Leveraged/Inverse ETFs Up More Than 15% in November
Via Talk Markets
7 Inverse ETFs Riding High on Nasdaq Sell-Off
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.